45 / 55
VENDOR PROFILE
such a wide net is cast. They had to do
that because of political pressure, but they
also knew that these regulations would
be progressively reduced and narrowed
down by litigation. FDA is used to that; it
is a way for them to operate.”
However, even if the hoped-for chang-
es come, many of the smaller manu-
facturers and vapor retailers will still
be unable to survive the winnowing of
the field. In fact, a significant number of
manufacturers are already “dumping”
products in an effort to exit the market—
and for good reason. Both paths to FDA
approval, substantial equivalence and
the pre-market tobacco applications,
will be expensive and time-consuming.
Still, there are also plenty of competitors
that hope to stay the course. “Everyone
who intends to continue to be a player
in this market was launching products
in advance of the August 8 deadline,” he
says. “I’ve seen some interesting stuff
that I wasn’t expecting.”
AN EXPANDING LINEUP
EAS is also expanding its offerings. The
company recently introduced Liquid Soul
Amaranth, a premium liquid brand made
with HydraVape MAX technology, a pro-
prietary process that uses tobacco-free
nicotine (TFN). Named for the Amaranth
flower, a blossom known to the Ancient
Greeks as “the flower that never fades,”
Amaranth was designed to produce a
consistent vape at any standard tempera-
ture, delivering powerful long-lasting fla-
vors with minimal vape tongue.
“Everyone who
intends to continue
to be a player in
this market was
launching products
in advance of the
August 8 deadline.
I’ve seen some
interesting stuff
that I wasn’t
expecting.”
82
TOBACCO BUSINESS INTERNATIONAL
SEPTEMBER/OCTOBER 2016